TY - JOUR
T1 - The ecosystem of health decision making
T2 - from fragmentation to synergy
AU - Schünemann, Holger J.
AU - Reinap, Marge
AU - Piggott, Thomas
AU - Laidmäe, Erki
AU - Köhler, Kristina
AU - Pōld, Mariliis
AU - Ens, Brendalynn
AU - Irs, Alar
AU - Akl, Elie A.
AU - Cuello, Carlos A.
AU - Falavigna, Maicon
AU - Gibbens, Michelle
AU - Neamtiu, Luciana
AU - Parmelli, Elena
AU - Jameleddine, Mouna
AU - Pyke, Lisa
AU - Verstijnen, Ilse
AU - Alonso-Coello, Pablo
AU - Tugwell, Peter
AU - Zhang, Yuan
AU - Saz-Parkinson, Zuleika
AU - Kuchenmüller, Tanja
AU - Moja, Lorenzo
N1 - Publisher Copyright:
© 2022 World Health Organization
PY - 2022/4
Y1 - 2022/4
N2 - Clinicians, patients, policy makers, funders, programme managers, regulators, and science communities invest considerable amounts of time and energy in influencing or making decisions at various levels, using systematic reviews, health technology assessments, guideline recommendations, coverage decisions, selection of essential medicines and diagnostics, quality assurance and improvement schemes, and policy and evidence briefs. The criteria and methods that these actors use in their work differ (eg, the role economic analysis has in decision making), but these methods frequently overlap and exist together. Under the aegis of WHO, we have brought together representatives of different areas to reconcile how the evidence that influences decisions is used across multiple health system decision levels. We describe the overlap and differences in decision-making criteria between different actors in the health sector to provide bridging opportunities through a unifying broad framework that we call theory of everything. Although decision-making activities respond to system needs, processes are often poorly coordinated, both globally and on a country level. A decision made in isolation from other decisions on the same topic could cause misleading, unnecessary, or conflicted inputs to the health system and, therefore, confusion and resource waste.
AB - Clinicians, patients, policy makers, funders, programme managers, regulators, and science communities invest considerable amounts of time and energy in influencing or making decisions at various levels, using systematic reviews, health technology assessments, guideline recommendations, coverage decisions, selection of essential medicines and diagnostics, quality assurance and improvement schemes, and policy and evidence briefs. The criteria and methods that these actors use in their work differ (eg, the role economic analysis has in decision making), but these methods frequently overlap and exist together. Under the aegis of WHO, we have brought together representatives of different areas to reconcile how the evidence that influences decisions is used across multiple health system decision levels. We describe the overlap and differences in decision-making criteria between different actors in the health sector to provide bridging opportunities through a unifying broad framework that we call theory of everything. Although decision-making activities respond to system needs, processes are often poorly coordinated, both globally and on a country level. A decision made in isolation from other decisions on the same topic could cause misleading, unnecessary, or conflicted inputs to the health system and, therefore, confusion and resource waste.
UR - https://www.scopus.com/pages/publications/85127501181
U2 - 10.1016/S2468-2667(22)00057-3
DO - 10.1016/S2468-2667(22)00057-3
M3 - Review article
C2 - 35366410
AN - SCOPUS:85127501181
SN - 2468-2667
VL - 7
SP - e378-e390
JO - The Lancet Public Health
JF - The Lancet Public Health
IS - 4
ER -